Tag: cancer
-
Forget Covid; AZ’s kicking in cancer
- 27 Aug 2021
While AstraZeneca’s reputation in Covid-19 vaccines was tarnished, the company is on a PBS roll in more familiar territory.
Read more -
‘Surviving comes at a cost’, says teenager
- 23 Aug 2021
Tamlin Hall is 17 and four years cancer-free but says surviving cancer was not the end of her fight. She tells Kayla Olaya of her reality, as well as her dreams.
Read more -
PBAC seeks to buzz WMozzies through
- 23 Aug 2021
A consumer hearing allowing patients to give lived-experience potentially inspired the PBAC’s first Facilitated Resolution pathway offer.
Read more -
Opdivo leapfrogs to Nov PBAC
- 16 Aug 2021
Update shows BMS a latecomer chasing another funded indication for its IO blockbuster, this time years after an initial TGA rejection.
Read more -
Cancer clinicians slam PBS ‘rationing’
- 23 Jul 2021
Australia is ‘in the last century’ for drug access and patients are missing out on commonly available drugs, leading oncologists state.
Read more -
Two score PBS fast track
- 05 Jul 2021
Two companies were offered the costly fast-track to a PBS listing while price has again been revealed as the stumbling block for failed PBAC submissions.
Read more -
Bayer, Merck, MSD at Nov PBAC
- 28 Jun 2021
Bayer will resubmit its pan-tumour drug, Merck brings a first to PBAC and MSD has a second attempt to expand IO blockbuster.
Read more -
Not all diseases equal at PBS, says LEO
- 23 Jun 2021
Eight cancer drugs PBS listed since August and only one eczema drug in 20 years reveal PBS favouritism, says Leo Pharma’s Ruchi Kanojia.
Read more